Embotelladora Andina stock: fair value
AKO-AThe fair value of Embotelladora Andina under our model is $70.49, the price is 64% below.
The fair value is an estimate from our model, not a price target.
Daily figure as of 13 Nov 2026
Valuation signal
Significantly undervaluedIn our model the price counts as cheap below $50.35 and expensive above $117.48 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $45.05 (cash-flow model) and $95.93 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is below both.
Calculated with a cost of equity of 10.8%. At 11.8% the fair value would be $66.80, at 9.8% it would be $76.01.
Where the number comes from
Half from the cash-flow model, half from earnings times the industry P/E (25.3).
Ten-year cash-flow model from smoothed free cash flow and its past growth until it reaches 5.8%. Discounted at 10.8% (floor: government bond yield 5.8% plus 5 percentage points, since beta 0.86 times the risk premium would give less); no analyst estimates were available.
Calculate with your own assumptionsThe calculation step by step
With these figures the cash flow model arrives at $45.05 per share: free cash flow for the next ten years, each year discounted to today at 10.8%, plus the terminal value for the years after. The table explains the calculation; it is not a recommendation.
Calculation as a table
| Year | Free cash flow | Source | Discount factor | Present value (discounted at 10.8%) |
|---|---|---|---|---|
| 2026 | CLP 204B | extrapolated at −1.6% | 0.9024 | CLP 184B |
| 2027 | CLP 205B | extrapolated at 0.6% | 0.8144 | CLP 167B |
| 2028 | CLP 210B | extrapolated at 2.2% | 0.7350 | CLP 154B |
| 2029 | CLP 216B | extrapolated at 3.3% | 0.6633 | CLP 144B |
| 2030 | CLP 225B | extrapolated at 4.0% | 0.5986 | CLP 135B |
| 2031 | CLP 236B | extrapolated at 4.6% | 0.5402 | CLP 127B |
| 2032 | CLP 247B | extrapolated at 4.9% | 0.4875 | CLP 120B |
| 2033 | CLP 260B | extrapolated at 5.2% | 0.4399 | CLP 114B |
| 2034 | CLP 274B | extrapolated at 5.4% | 0.3970 | CLP 109B |
| 2035 | CLP 289B | extrapolated at 5.5% | 0.3583 | CLP 104B |
| Step | Value |
|---|---|
| Sum of present values (ten years) | CLP 1T |
| Terminal value: cash flow 2035 × (1 + 5.8%) / (10.8% − 5.8%) | CLP 6T |
| Present value of terminal value (× 0.3583) | CLP 2T |
| Equity value (sum plus present value of terminal value) | CLP 4T |
| Shares (diluted) | 157.83M |
| Value per share (equity value divided by shares) | CLP 22,490 |
| Per share as traded (converted ÷ 499) | $45.05 |
| Earnings per share, last twelve months | $3.79 |
| × 25.3 (industry P/E) | $95.93 |
| Fair value (average of both parts) | $70.49 |
The model uses free cash flow after interest, which belongs to shareholders, discounted at the cost of equity. Net debt is therefore not deducted again.
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 11 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 4 Nov 2026)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.